SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/19/2019
Entire Document
 

 

7 ▪ Pernix is a specialty pharmaceutical company with a scalable commercial platform focused on pain and CNS ▪ Differentiated product portfolio consisting of both branded and generic products led by Zohydro ® ER with BeadTek ® and Silenor ® ▪ Fully integrated and dedicated specialty sales force focused on promoting 2 growing brands in pain and CNS, supplemented by best - in - class prescription fulfillment service: ▪ Dedicated sales force with high potential and expertise in Pain and CNS, highlighted by a proven track record of driving growth ▪ Recently purchased a 10% interest in Nalpropion , which owns worldwide rights to Contrave ® , a market - leading branded prescription medication indicated for weight - loss; Pernix’s management of Nalpropion provides meaningful incremental economics to the Company ▪ Experienced specialty pharmaceutical management team with significant turnaround experience Diverse Product Portfolio Generics [including Authorized Generic] Company Highlights Owned and marketed by Nalpropion